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Purposes: to identify the prevalence of the use of psychiatric drugs among patients admitted to 
medical and surgical clinics of a general hospital, and also the factors related to the consumption 
of this type of medication. Method: this is a transversal, descriptive, correlational study with 
quantitative analysis. For the collection of data, there was use of structured interviews and 
also reference to medical files. Results: there was confirmation of a high prevalence of users of 
psychiatric drugs, which was associated to the female sex, to people who do not practice Roman 
Catholicism, and admittance to the clinic not covered by the Single Health System (Sistema 
Único de Saúde – SUS), as well as the presence of common mental disorders. Benzodiazepine 
drugs were the most commonly used psychiatric drugs. Among the total number of users, 
there has been the identification of patients who were not aware that they were receiving 
such medication. Doctors who are not psychiatrists were responsible for most prescriptions of 
psychiatric drugs. Conclusions: this signals the need to prepare health professionals to deal 
with psychological and social problems commonly found in clinical practice, in order to promote 
the rational use of psychiatric drugs.
Descriptors: Psychotropic Drugs; Inpatients; Safety Management.
Consumption of psychiatric drugs by patients of medical and surgical 
clinics in a general hospital
949
www.eerp.usp.br/rlae
Shirama FH, Miasso AI.
Introduction
Psychiatric drugs are an important tool in the 
treatment of those who have clear recommendations as 
to their use. However, there is a great world prevalence 
of consumption of psychiatric drugs by the general 
population. The growth in the use of these drugs has 
been blamed on the increased frequency of diagnosis 
of  the frequency of psychiatric problems in the country, 
the introduction of new psychiatric drugs on the market 
and also new therapeutic recommendations for existing 
psychiatric drugs(1). International studies have also 
shown the growing use of this type of medication.
A study about the prevalence of psychiatric drugs 
among North American adults found an increase in 
consumption, from 6.1% for 1988-1994 to 11.1% to 
1999-2002(2). In France, a research study showed that 
the occurrence of use of such drugs in France is similar 
to those of the United Kingdom (about 2.0%), the 
Netherlands (2.9%) and Germany (2.0%)(3).
Among people living in rest homes in Austria, 
with an average age of 81 years, the occurrence 
of consumption of psychiatric drugs was 74.6%(4). 
In Pakistan, it was observed that more than 40% of 
adult patients of a hospital outpatient service took 
psychological drugs without a prescription and 78% had 
used them for more than six months. More than 85% 
were using this type of medication to induce sleep, and 
59% for relaxation(5).
Such data about the consumption of psychiatric 
drugs in other countries matches the results found in 
Brazil and, considering the concern about the theme, 
research has been developed on a national scale.
In Pelotas, State of Rio Grande do Sul, the 
occurrence of consumption of psychiatric drugs by people 
aged 15 and over was 9.9%. The greatest consumption 
of these drugs was, by far, that of the female sex, more 
advanced age, medical diagnosis of high blood pressure, 
and also the use of medical services(1).
A survey in the city of Botucatu, State of São Paulo, 
with people aged 15 and over, has shown that 13.3% 
of the sample mention that they have used at least one 
psychiatric drug in the three days immediately before 
the survey. Being female and the presence of common 
mental disorder (CMD) have remained as strongly 
associated to the use of benzodiazepine drugs. A higher 
family income and advanced age were associated to the 
use of psychological drugs(6).
The data related to the consumption of psychological 
drugs is worthy of attention. Here we highlight that if 
the data is relevant in the general population, there is 
growing concern with patients in hospital, especially in 
medical and surgical clinic, as not only does this present 
chronic conditions with the potential for the use of several 
types of medication, but also the literature has shown a 
high occurrence of psychiatric disorders in people with 
medical illness. A study through a systematic review of 
the literature has identified a high occurrence of mental 
illness in about 20% of patients in the cardiology area, 
25% in nephrology and 30% of patients with liver 
problems, and has synthesised the psychological drugs 
that are most appropriate for the aforesaid groups of 
medical pathologies(7).
A recent study carried out in a Brazilian hospital 
which deals with several clinical and surgical specialities, 
has shown a general occurrence of depression in 53.3% 
of the sample investigated, with no patient having a 
prior history of depressive disorder mentioned on the 
patient’s file. The psychological drugs most commonly 
used by the patients as mentioned were antidepressive 
drugs, followed by ansiolytics(8).
The context as described shows that the researchers 
have investigated the presence of depression and other 
mental illnesses in hospitalised patients, particularly in 
medical and surgical clinics. However, there is a gap in 
the literature in relation to the investigation of the use 
and indication of psychiatric drugs and the presence, 
within the aforementioned clientele, of anxious symptoms, 
depressives or somatoforms that do not fit perfectly in the 
criteria to diagnose mental illness. The symptoms described 
characterises Common Mental Disorders (CMD)(9).
Here we highlight the fact that such disorders 
do not come under any of the psychiatric diagnostic 
categories does not reduce the degree of suffering 
experienced by the patients, as also their shelter needs 
and, in some cases, treatment with medication. Due 
to the possibility of worsening of the clinical illnesses, 
the prescription of psychiatric drugs for people with 
mental problems diagnosed or with CMD shall be made 
carefully in patients with medical and surgical clinics. 
Even though currently there is a trend towards the 
indiscriminate use of psychiatric drugs, we estimate that 
there is underdiagnosis and inappropriate treatment 
of the patients with mental disorders in medical and 
surgical clinics, mainly due to the difficulty for the clinics 
to deal with patients presenting psychiatric symptoms(8).
The high occurrence of mental disorders among 
patients in medical and surgical clinics, the contradictions 
in the literature in relation to the indiscriminate use 
of psychiatric drugs and subdiagnosis and inadequate 
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treatment of mental disorders in clinical patients, as also 
the scarcity of research studies seeking to identify the 
prescription of psychiatric drugs in the aforementioned 
clinics, make evident the relevance of this survey. In 
the light of this, the main purpose of this study was to 
identify the prevalence of the use of psychiatric drugs 
among patients in medical and surgical clinics of a 
general hospital, and the factors related to consumption 
of this medication.
Methods
This is a transversal cut study, with descriptive 
correlational design and quantitative analysis. This was 
carried out in a large general philanthropic hospital in 
the interior of the state of São Paulo. To reach the aims 
of the study, the collection of data was carried out in the 
general medicine and surgical clinic of this institution.
This study was carried out after approval by the 
Research Ethics Committee (Protocol 396/2010) and 
the participants signed an Informed Consent Form, 
according to Resolution No. 196/96 of the National 
Board of Health (Conselho Nacional de Saúde – CNS).
All the hospital beds in the sectors created were 
visited, and the patients who were 18 years old or 
over who were occupying these beds and who could 
communicate verbally were invited to participate. When 
the visited hospital bed was vacant, a new visit was then 
carried out at the moment of its occupancy. When the 
occupier of a bed refused to participate, this hospital bed 
was never visited again.
For data collection, between January and December 
2011, an interview was carried out based on a 
structured questionnaire, developed by the researchers, 
with questions about demographic, social, economic, 
and pharmacotherapeutic variables and also about the 
patient’s health record. There was the verification of 
the preference of the patient in relation to the carrying 
out of the interview in the hospital bed or in a private 
location. Due to the  clinical condition, some patients 
preferred to be interviewed in bed. The interviews with 
the other patients were carried out in a private room in 
the patient admittance section.
In this study, the aim was to assess a wider range of 
variables using one same sample, providing a wider view 
of the issue at hand. Within such variables, the CMDs 
stand out, and these can be shown by means of several 
symptoms, such as unspecific somatic complaints, 
irritability, insomnia, nervousness, headaches, fatigue, 
forgetfulness and lack of concentration, as also a host of 
expressions of symptoms that could be characterised as 
depressive, anxious or somatoform(9).
To detect the presence of CMD in individuals 
who had no mental problems diagnosed, during the 
interview the SRQ-20 questionnaire (Self-Reporting 
Questionnaire) was applied. The SRQ is an instrument 
for psychiatric tracking, originally consisting of 30 
items(10). The Brazilian version of the SRQ (SRQ-20 – the 
version with 20 questions for tracking of common mental 
disorders) was validated in the early 1980s(11). Another 
study(12), assessed the performance of SRQ-20 as a 
tracking instrument, and recommended this instrument 
to be used in clinical activities by any professional. The 
answer is considered positive when the interviewee says 
“Yes” to eight or more questions.
Later, a consultation was made to the files of the 
patients involved. At this stage, seeking to collect all 
necessary data, and an outline prepared by the researchers 
was used. The first question in this outline referred to the 
identification of the prescription of psychiatric drugs to the 
patients. In this way, the prescription of the medication 
was observed, seeking the identification of psychiatric 
drugs that the patient is not aware of receiving. The 
second question refers to the reason of the introduction 
of the psychiatric drugs, on medical assessment. When 
the psychiatric drug was assessed and the patient was 
not aware of the use of the drug, then there was a review 
of the clinical development of the health professionals, 
seeking to check the indication of the aforementioned 
prescription. The third issue seeks to identify if the 
prescription of psychiatric drugs is made by a psychiatrist 
or a doctor in other areas. There was also an investigation 
to see if the patients were using the medication prior to 
being admitted for treatment, or if the prescription was 
introduced during the process.
To assess the influence of independent variables 
on the consumption of psychiatric drugs, statistical 
associations were investigated using the Chi-square test, 
with the association hypothesis being accepted when 
the value of p found was less than 0.05. To estimate 
the relative risk, the model of log-binomial regression, 
simple and multiple, as the response was binary (use of 
Psychiatric Drugs = Yes or No). The adjustment of the 
model was made through the PROC GENMOD procedure 
of SAS software, version 9.0.
Results
This study had the participation of 93 patients 
admitted to the medical and surgical clinics of the 
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hospital considered in the study. It was identified that 
36 (38.7%) patients were using psychiatric drugs. 
Statistical associations were investigated (Chi-square 
test) between the use of psychiatric drugs (dependent 
variable) and the other independent variables: sex, 
age, hospital ward, funding of hospital stay, educational 
level, marital status,  religion, employment situation, 
income, presence of chronic illnesses, and the result 
obtained in the SRQ-20 instrument. A statistically 
significant association has been identified between the 
consumption of psychiatric drugs and a positive result 
on the SRQ-20 test, female sex, hospital admittance not 
paid for by the Brazilian National Health Service (SUS), 
and being a non-Catholic (Table 1). In  multivariable 
analysis, these variables remained associated to the 
consumption of psychiatric drugs.
Table 1 - Distribution of the subjects of the study, according to the prevalence of the use of psychiatric drugs and the 
variables investigated. Barretos, Brazil, 2011
Variables
Use of psychiatric drugs
p-valueNo Yes Total
N % N % N %
Sex <0.01
Female 26 48.1 28 51.9 54 100
Male 31 79.5 08 20.5 39 100
Age 0.08
Up to 30 17 81.0 04 19.1 21 100
31 to 50 20 60.6 13 39.4 33 100
51 or over 20 51.3 19 48.7 39 100
Hospital Ward 0.08
Medical clinic 38 55.9 30 44.1 68 100
Surgical clinic 19 76.0 06 24.0 25 100
Funding of hospital stay <0.01
Not SUS 06 33.3 12 66.7 18 100
SUS 51 68.0 24 32.0 75 100
Educational Level 0.21
Illiterate or primary education 24 54.6 20 45.5 44 100
Secondary or University 33 67.4 16 32.7 49 100
Marital Status 0.35
Without partner 26 56.5 20 43.5 46 100
With partner 31 66.0 16 34.0 47 100
Religion <0.01
Catholic 43 71.7 17 28.3 60 100
Evangelical and Others 14 42.4 19 57.6 33 100
Employment Situation 0.11
Inactive 30 54.6 25 45.5 55 100
Active 27 71.1 11 29.0 38 100
Income 0.15
Up to 1 minimum wage (MWg) 20 50.0 20 50.0 40 100
1 to 3 MWg 29 70.7 12 29.3 41 100
Over 3 MWg 08 66.7 04 33.3 12 100
Chronic Illnesses 0.23
Yes 26 55.3 21 44.7 47 100
No 31 67.4 15 32.6 46 100
SRQ-20 0.03
Positive 15 53.6 13 46.4 28 100
Negative 42 76.4 13 23.6 55 100
In Table 1, we see that there has been a higher 
percentage of consumption of psychiatric drugs among 
patients 51 years old and over, and also those admitted 
to a  medical clinic, even though there has not been 
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Table 2 - Distribution of prescriptions of psychiatric 
drugs by hospital ward, Barretos, São Paulo, 2011
Psychiatric Drug
Surgical 
Clinic
Medical 
Clinic Total
N % N % N %
Benzodiazepines 05 17.9 23 82.1 28 100
Antidepressive Drugs 04 28.6 10 71.4 14 100
Antipsychotic Drugs - - 02 100 02 100
any statistically significant association between these 
variables and the consumption of psychiatric drugs 
(p=0.08). Similarly, there has not been any statistically 
significant association between consumption of psychiatric 
drugs and scholastic level (p=0.21), marital situation 
(p=0,35), employment situation (p=0.11), income 
(p=0.15) and chronic diseases (p=0.23). However, it has 
also been observed that the percentage consumption of 
psychiatric drugs was higher among illiterates and those 
who have no more than a basic education (45.4%), 
between the patients who do not have a partner (43.5%), 
inactive (45.5%), with a monthly income of up to one 
national minimum wage (50%) and who have chronic 
diseases (44.7%). We also mention the fact that, in this 
study, 28 of the patients (33.73%) were positive in the 
SRQ-20 test.
It was also observed that, out of the 36 patients 
who used psychiatric drugs, eight (22.2%) receive an 
association between more than one class of the medication 
as mentioned. Out of this total, seven patients used the 
association between benzodiazepine and antidepressive 
drugs, and one used an association of a psychiatric drug 
with an antidepressive drug. Benzodiazepines (BDZs) 
were the psychiatric drugs most used within the sample 
(n=28; 63.6%), followed by antidepressives (n=14; 
31.8%). Among the patients of the medical clinic, the 
most commonly used medications were benzodiazepines 
and antidepressive drugs respectively with usage rates 
of 82.1% and 74.1%. Psychiatric drugs were used 
by two people in the sample. At the surgical clinic, 
antidepression drugs were used more often (28.6%).
The main prescription case for BDZs, as mentioned 
by the patients, was “to sleep” (n=15, 53.6%). The 
other indications as mentioned were for “depression” 
(n=4; 14.3%) and “anxiety” (n=2, 7.1%). Here 
we mention that for 25% (n=7) of the patients the 
prescription of the medicine was written on the medical 
file, hence the patient was unaware of its use. In the 
clinical development as mentioned on the patient’s 
medical file, there was no mention of the reason why 
the psychiatric drug was prescribed. Cases where the 
patients received this medication prior to anaesthesia 
were not considered.
In relation to antidepressive drugs, for 50% of 
the patients (n=7), such medication was prescribed for 
“depression”. Prescriptions for “anxiety” were reported 
by 14.3% of the patients, and “to induce sleep” by 
another 14.3%. Here we must draw attention to the fact 
that in 21.4% of cases (n=3), there was no indication 
of the reason why the psychiatric drug was prescribed, 
as this information was not found on the medical file, 
and the patient was not aware that he or she was 
using the medication. Out of the two patients reporting 
the use of antipsychotic drugs, one mentioned using 
it for “depression” and the second as medication for 
“depression and anxiety”.
It was identified that most of the prescriptions 
(n=31, 70.4%) of psychiatric drugs were passed 
by doctors not specialised in psychiatry. The most 
commonly prescribed medication in this group was 
that of antidepression drugs (n=6; 46,2%) followed 
by benzodiazepine drugs (n=5, 38.5%). Antipsychotic 
drugs were only prescribed by psychiatrists. Doctors 
not specialised in psychiatry were responsible for most 
prescriptions of benzodiazepines (n=23; 74.2%), 
followed by antidepression drugs (n=8; 25.8%). 
Another item that was surveyed was the occurrence of 
use of such medication at some point in life, without a 
medical prescription. Out of the total number of users 
of psychiatric drugs, two (5.6%) reported this practice. 
In these cases, the medication was obtained by means 
of family members. In addition, most of the patients 
(n=26, 72.2%) in this study did not have any kind of 
therapy aside from pharmacological treatment.
Out of the 36 patients with a prescription 
for psychiatric drugs, 23 were already using this 
medication prior to admittance to hospital and, out of 
these, 10 had a medical diagnosis of mental disorders. 
Here, we must mention that 13 of the patients started 
the use of this therapeutic class while being treated 
in hospital.
All those (n=10, 100%) who had a diagnosis of 
mental illness used psychiatric drugs. Among patients 
without a diagnosis of mental illness and a positive 
result on SRQ-20, 46.4% of these (n=13) used this 
medication. Among those without a diagnosis of mental 
illness and who had a negative result in SRQ-20, 26.6% 
(n=13) used psychiatric drugs.
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Discussion
The prevalence of consumption of psychiatric drugs, 
as shown in this study, is high (38.7%), as this is not 
a segment of the psychiatric field and also considering 
the data of prevalence among the general population, 
as informed by the specialised literature(6). This high use 
of psychiatric drugs must be monitored with care, as it 
could bring negative repercussions to both individual and 
group health. Especially among patients who have been 
admitted for hospital treatment and who are receiving 
other medication at the same time, there is a high risk of 
occurrence of interaction between medication(13). Another 
factor to be borne in mind is the possibility of side effects 
which such medication can bring, as also dependence on 
use, causing additional health problems for the individual.
Here we mention the prevalence, in this study, of 
28 (33.7 patients) who have shown positive results in 
SRQ-20. Also in agreement with the literature, we have 
found a statistically significant association between the 
consumption of psychiatric drugs and a positive result 
using the SRQ-20 instrument(6). One cannot deny the 
importance of psychiatric drugs for the treatment of 
diagnosed mental disorders, with the correct adaptation 
and also the correct prescription of such drugs. The 
concern lies in the symptomatic use of the psychiatric 
drugs and the lack of correct diagnosis of such ailments, 
leading to the lack of success of the proposed therapy 
and also damage to the individual(8).
The female sex has shown statistical association with 
the consumption of psychiatric drugs. In this context, 
it is worth mentioning that we have also identified an 
association between femaleness and a positive result 
on SRQ-20. The presence of a CMD, depending on the 
specific disorder and the suffering generated by its 
symptoms, has an initial indication of the therapy using 
medication, which can contribute to this panorama. We 
add to this the fact that women use health services more 
regularly than men(14); this aspect may, in part, explain 
the greater consumption shown by this clientele.
The main determining factor for the use of health 
services in Brazil is whether the person has health 
insurance, with the illness issue being secondary(15). In 
this context, considering that access to health services 
is made easier for those who have health insurance or 
the financial clout to undergo private treatment, the 
association between the consumption of psychiatric 
drugs and the patients admitted to hospital through 
health insurance agreements or private treatment 
schemes could be better understood.
In relation to religion, we have observed an 
association between the consumption of psychiatric 
drugs and not being Catholic. In the specialised 
literature, we have not seen any other study show a 
relationship between psychiatric drugs and religion. 
We therefore see that, even though this is a relevant 
variable to be considered when the consumption of 
psychiatric drugs is concerned, this has not yet been 
given its due importance by researchers.
In relation to the prescription of benzodiazepine 
drugs (BDZ) as reported by patients, the specialised 
literature recommends, preferably, medication which 
does not belong to the aforementioned class, as also 
psychotherapeutic intervention, or even the combination 
of both, for the treatment or symptom relief of states 
of anxiety or insomnia(16). It is also known that there 
are several other non-pharmacological strategies which 
could be implemented by health professionals, including 
the nurse, for promotion of sleep, favouring the rational 
use of medicines. Strategies mentioned include the 
use of relaxation techniques, encouragement of warm 
baths before sleeping and avoidance of daytime naps, 
avoidance of caffeine, among others.
The BDZs, causing drowsiness and reduction of 
reflexes, has the potential to promote falls with the 
resulting reduction in autonomy and in the quality of 
life experienced by the patient, thereby bringing an 
overload of care responsibilities for family members, as 
well as costs for the public health system(17). In addition, 
studies have observed an association between the 
use of BDZ and fractures and falls among the elderly 
population(18). These aspects are relevant, considering 
that in this study the consumption of psychiatric drugs 
was larger among patients aged 51 years and over. 
Studies describe medical prescription as a factor of great 
importance in the maintenance of chronic use of BDZs, 
suggesting an undue medical attitude(16).
The use of antidepressive drugs, like the BDZs, 
may bring health risks both in relation to the side effects 
as also interaction between medication, especially when 
there is no careful prescription of such drugs. A survey 
carried out in a state-run hospital observed that 25.3% 
of the patients admitted to general infirmaries (non-
psychiatric wards) used medication presenting a risk 
when used together with antidepressives(19).
A research study that investigated interactions 
between antidepressive drugs and medication against 
high blood pressure and blood sugar, often used in 
medical clinic units, as is the case of the present 
research study, observed that, among patients using 
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antidepressives, 23.4% were exposed to interactions 
that occurred through pharmacokinetic mechanisms 
and 61.7% were exposed to interactions through 
pharmacodynamic mechanisms of synergy, and 15.9% 
by both forms at the same time(20).
The present work has also observed that, among 
patients who have been prescribed psychiatric drugs, 
25% and 21.4% were also consuming, respectively, 
benzodiazepines and antidepressive drugs, without being 
aware of this fact. In all these cases, these medicines 
were introduced during the period of hospitalisation. 
This is a high percentage, considering the importance 
of the patient’s participation in the process of reaching 
a decision about the appropriate therapy. This shows 
the worrying and inadequate interaction between health 
professionals and patients, showing the lack of guidance 
provided to those who need it. There is a need for a 
review in the qualifications of the professionals, and also 
the creation of greater awareness of health professionals 
who already act with the individuals, seeking the 
protection of patient rights, based on the principles of 
bioethics.
The largest prescription of benzodiazepines by 
doctors who are not psychiatrists could be related to 
the difficulty that these have  in diagnosis of mental 
disorders such as depression(6,8). This disorder, given 
as an example, could cause insomnia and irritability, 
among many other symptoms, thereby leading to 
a greater prescription of ansiolytic drugs for such 
problems. This would lead to a merely symptomatic 
treatment of the cases, delaying the correct treatment 
and also the recovery of the patient(8). In addition, such 
medication may lead to dependence, a characteristic of 
benzodiazepines(16).
The habit of self-medication at some point in life 
has also been identified, thereby making evident the 
need for effective inspection and building of awareness 
among those who were part of the pharmaceutical 
market, as this practice could lead to undesirable 
effects, iatrogenic illnesses and masking of evolutive 
diseases.
In this study, we observed a high percentage of 
individuals as detected in SRQ-20 that used psychiatric 
drugs without having been diagnosed, meaning they 
could be receiving symptomatic treatment. The data 
also show there may be the use of psychiatric drugs in 
an imprudent or unnecessary way, with the identification 
of the use of such pharmaceutical products by patients 
without the appropriate diagnosis and with a negative 
result on SRQ-20s.
Conclusions
The present research has shown that, apart from 
the high prevalence of the use of psychiatric drugs 
in the medical and surgical clinics under study, the 
inappropriate use of these medications could be taking 
place. This panorama could be related to the difficulty 
in identification of mental disorders by doctors who 
are not specialised in psychiatry, considering that most 
prescriptions have been made by these professionals. 
In addition, there has been the identification of lack of 
awareness of the consumption of this medication by 
many of these individuals, which amounts to a fault not 
only on the part of the professional person prescribing 
the drug, but also of the person who is responsible for 
administration of the medication. There has also been a 
report of the practice of self-medication at some point in 
life, and this aspect could be related to lack of awareness 
among the general population and also in the Brazilian 
health system.
We also mention that studies on mental illnesses, 
particularly depression, and also the use of psychiatric 
drugs by patients in medical and surgical clinics, have 
been developed, but the specialised literature has not 
identified any research studies about the prevalence of 
CMDs and their relationship with the consumption of 
psychiatric drugs within this consumer group. Thus, this 
study makes a significant contribution to clinical practice 
on investigating such variables, identifying a statistically 
significant association between them.
However, the results shown must be analysed 
considering the limitations of the study. The sample size, 
and also the fact that the study was conducted in only one 
hospital institution, bring restrictions on generalisations. 
In addition, the scarcity of studies that have investigated 
the variables of interest as described, with this specific 
population, makes it difficult to establish a comparative 
analysis of the results obtained and suggests the need 
for new investigations exploring this theme.
We also stress the need for the elucidation of the 
association between the consumption of psychiatric drugs 
and religiousness through future studies, analysing the 
way in which this variable acts as a determining factor 
for consumption, or not.
There is a need for an important change in the 
teaching of psychiatry in undergraduate courses in 
medicine and nursing, as also in the attitudes taken 
up by doctors and nurses, when faced with CMDs and 
also users of psychiatric drugs. These professionals 
must be trained to be able to identify and deal with the 
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psychological and social problems often found in clinical 
practice, including CMDs, so as to promote the rational 
use of psychiatric drugs and the implementation of non-
pharmacological strategies that allow the handling of 
mental disorders, in partnership with the other members 
of the multidisciplinary study.
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